0
Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

1
Letters   |    
Patients' Views on Suicidality and Antidepressants
Jordana R. Muroff; Scott Y. H. Kim
Psychiatric Services 2006; doi: 10.1176/appi.ps.57.5.723

To the Editor: Reports in the popular media and public health advisories issued by the U.S. Food and Drug Administration have raised concerns that antidepressant medications may heighten the risk of suicidal thoughts and behaviors (1,2,3,4). We explored how adult patients with a diagnosis of major depression from an academic ambulatory psychiatric clinic might be affected by these news stories about antidepressants. As part of a larger anonymous survey on quality of life and depression, we examined two questions. Are patients paying attention to these stories in the media? Is the news affecting their confidence in antidepressant medications?

In the written survey, 630 patients were asked, "In the past several months, there have been several news stories about a potential unexpected effect of taking certain types of antidepressants. What has been the focus of these news stories?" This question was followed by, "How closely have you been following the stories?" A total of 278 patients returned the survey, for a 44 percent response rate. Of these, 242 (87 percent) completed the section on news stories about antidepressants. Those who completed this section did not differ from those who did not in gender, race, age, severity of depression, suicidality, and stigma concerns.

A majority of respondents (191 respondents, or 79 percent) correctly endorsed "possible increase in suicidal thoughts and behaviors" as the focus of the news stories. Of these, 45 percent followed the news stories somewhat or very closely. Logistic regression models showed that how closely the patients followed the stories was not influenced by their demographic characteristics, quality of life, severity of depression, experiences with suicidality, or concerns about stigma. Severity of depression and experiences with suicidality were measured with use of the Beck Depression Inventory (BDI) (5).

To measure how the news stories affected patients' attitudes toward taking antidepressants, we asked "Thinking back to the news stories, how have they affected your feelings about antidepressant medications?" and "Have you talked about the news stories with your psychiatrist?" Of the 191 respondents who correctly identified the content of the news stories, most (148 respondents, or 78 percent) reported that the news had "no effect" on their attitudes about taking antidepressants. In addition, the responses were not associated with demographic characteristics, current quality of life, experiences with suicidality, or stigma concerns.

Twenty-nine patients who reported feeling less willing to take antidepressants because of the news stories differed from those who reported not being affected by the stories. The 29 patients had more severe depression as indicated by elevated BDI scores (β=.060, p<.01), followed the news stories more closely (β=.949, p=.03), and talked more often with their psychiatrists about the news stories (β=2.504; p<.001). However, only 14 of the 29 patients (48 percent) who felt less willing to take medications reported talking with their psychiatrists about the stories.

In summary, a vast majority of patients being treated for depression in this clinic either did not pay attention to or were unaffected by recent news on antidepressants. However, the small minority who reported that they were less willing to take antidepressants because of the news stories seemed to have more severe depression, and only half of these patients reported talking with their psychiatrists about the news stories.

We suggest that psychiatrists consider probing for patients' reactions to these news stories as a possible contributor to nonadherence, especially among patients with relatively severe symptoms.

Dr. Muroff is affiliated with the Health Sciences Research and Development Center for Practice Management and Outcomes Research at the Veterans Affairs Ann Arbor Healthcare System in Ann Arbor, Michigan. She and Dr. Kim are with the Center for Behavioral and Decision Sciences in Medicine at the University of Michigan in Ann Arbor. Dr. Kim is also with the bioethics program and the department of psychiatry at the university.

FDA Public Health Advisory: Reports of Suicidality in Pediatric Patients Being Treated With Antidepressant Medication for Major Depressive Disorder (MDD). Washington, DC, US Food and Drug Administration, Oct 27, 2003. Available at www.fda.gov/cder/drug/advisory/mdd.htm
 
FDA Public Health Advisory: Worsening Depression and Suicidality in Patients Being Treated With Antidepressant Medications. Washington, DC, US Food and Drug Administration, Mar 22, 2004. Available at www.fda.gov/cder/drug/antidepressants/antidepressanstpha.htm
 
FDA Talk Paper: FDA Reviews Data for Antidepressant Use in Adults. Washington, DC, US Food and Drug Administration, July 1, 2005. Available at www.fda.gov/bbs/topics/answers/2005/ans01362.html
 
FDA Public Health Advisory: Suicidality in Children and Adolescents Being Treated With Antidepressant Medications. Washington, DC, US Food and Drug Administration, Oct 15, 2004. Available at www.fda.gov/cder/drug/antidepressants/ssripha200410.htm
 
Beck AT, Ward CH, Mendelson M, et al: An inventory for measuring depression. Archives of General Psychiatry 4:561-571, 1961
 
+

References

FDA Public Health Advisory: Reports of Suicidality in Pediatric Patients Being Treated With Antidepressant Medication for Major Depressive Disorder (MDD). Washington, DC, US Food and Drug Administration, Oct 27, 2003. Available at www.fda.gov/cder/drug/advisory/mdd.htm
 
FDA Public Health Advisory: Worsening Depression and Suicidality in Patients Being Treated With Antidepressant Medications. Washington, DC, US Food and Drug Administration, Mar 22, 2004. Available at www.fda.gov/cder/drug/antidepressants/antidepressanstpha.htm
 
FDA Talk Paper: FDA Reviews Data for Antidepressant Use in Adults. Washington, DC, US Food and Drug Administration, July 1, 2005. Available at www.fda.gov/bbs/topics/answers/2005/ans01362.html
 
FDA Public Health Advisory: Suicidality in Children and Adolescents Being Treated With Antidepressant Medications. Washington, DC, US Food and Drug Administration, Oct 15, 2004. Available at www.fda.gov/cder/drug/antidepressants/ssripha200410.htm
 
Beck AT, Ward CH, Mendelson M, et al: An inventory for measuring depression. Archives of General Psychiatry 4:561-571, 1961
 
+
+

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Related Content
Books
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 1.  >
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 10.  >
Dulcan's Textbook of Child and Adolescent Psychiatry > Chapter 18.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 53.  >
Dulcan's Textbook of Child and Adolescent Psychiatry > Chapter 18.  >
Topic Collections
Psychiatric News
APA Guidelines
PubMed Articles